CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioSino Bio-technology and Science Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioSino Bio-technology and Science Inc
Changping Business Hotel Opposite,No.27,
Chaoqian Road, Science and Technology
Phone: +86 1080117700p:+86 1080117700 BEIJING, BEJ  102200  China Ticker: 82478247
Business Summary
Biosino Bio-Technology and Science Inc is a China-based company primarily engaged in the research and development, manufacture, sale and distribution of in-vitro diagnostic reagents. The Company’s main products include clinical chemistry, immunological diagnostic products, molecular diagnostic products, hematology diagnostic products, medical clinical nutrition diagnostic products and related analytical instruments and raw materials. The Company’s products are mainly used for the diagnosis of liver function, lipids, renal function, myocardial, special proteins, trace elements, and sugar metabolism. The Company mainly conducts its business in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board LebinWu 61 8/3/2020
President, Executive Director PengChen 48 5/25/2023 12/7/2021
Executive Vice Chairman of the Board ZhengyongChen 61 12/13/2024 5/25/2023
10 additional Officers and Directors records available in full report.

Business Names
Business Name
8247
Biosino Bio-Technology and Science Inc.

General Information
Number of Employees: 554 (As of 6/30/2024)
Outstanding Shares: 144,707,176 (As of 6/30/2024)
Stock Exchange: HKG
Fax Number: +86 1080117026


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 27, 2025